美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPDR S&P Biotech ETF

124.53

+0.60990.49%

成交量：384.37萬

成交額：4.78億

市值：76.96億

市盈率：6.83

高：125.33

開：122.71

低：122.55

收：123.92

52周最高：132.09

52周最低：66.66

股本：6,180.00萬

流通股本：6,180.00萬

量比：0.90

換手率：6.22%

股息：0.45

股息率：0.36%

每股收益(TTM):18.23

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

高盛持倉-0.94%

ETF&股票定投概念-0.94%

資金流向

資金流入：

資金流出：

新聞資訊

廣州：推動具身智能機器人商業化，拓展智能機器人在工業製造、家庭服務、醫療健康等領域的應用

印孚瑟斯擬收購兩家美國諮詢公司，以加強醫療保健和保險技術產品組合

醫療保健板塊動態速覽：市場焦點解析

中銀基金青黃不接，新人李文廣成「帶頭大哥」

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/XBI"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":124.5299,"timestamp":1774541076211,"preClose":123.92,"halted":0,"volume":3843656,"delay":0,"changeRate":0.00492172369270494,"floatShares":61800000,"shares":61800000,"eps":18.23,"marketStatus":"交易中","change":0.6099,"latestTime":"03-26 12:04:37 EDT","open":122.71,"high":125.33,"low":122.55,"amount":478391246.30108,"amplitude":0.022434,"askPrice":124.5,"askSize":300,"bidPrice":124.48,"bidSize":241,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774555200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":123.92,"sharesOutstanding":63325000,"nav":119.517354,"aum":7185980897.54,"dividendRate":0.003582,"bidAskSpread":0.000205,"preHourTrading":{"tag":"盘前","latestPrice":122.82,"preClose":123.92,"latestTime":"09:29 EDT","volume":10221,"amount":1255638.136734,"timestamp":1774531741035,"change":-1.1,"changeRate":-0.008877,"amplitude":0.005003},"postHourTrading":{"tag":"盘后","latestPrice":123.92,"preClose":123.92,"latestTime":"19:58 EDT","volume":263669,"amount":32673988.5942,"timestamp":1774483088699,"change":0,"changeRate":0,"amplitude":0.004358},"volumeRatio":0.895139,"impliedVol":0.3744,"impliedVolPercentile":0.9243},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":61800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.895139,"shares":61800000,"dividePrice":0.4461,"high":125.33,"amplitude":0.022434,"preClose":123.92,"low":122.55,"week52Low":66.66,"pbRate":"--","week52High":132.09,"institutionHeld":0.8511,"latestPrice":124.5299,"committee":-0.032702,"eps":18.23,"divideRate":0.003582,"volume":3843656,"delay":0,"ttmEps":18.23,"open":122.71,"prevYearClose":121.93,"prevWeekClose":120.31,"prevMonthClose":127.37,"prevQuarterClose":121.93,"fiveDayClose":122.33,"twentyDayClose":127.67,"sixtyDayClose":123.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XBI","amount":0.002687,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.045491,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622565038","title":"廣州：推動具身智能機器人商業化，拓展智能機器人在工業製造、家庭服務、醫療健康等領域的應用","url":"https://stock-news.laohu8.com/highlight/detail?id=2622565038","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622565038?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 18:05","pubTimestamp":1774519500,"startTime":"0","endTime":"0","summary":"格隆汇3月26日｜广州市人民政府办公厅印发《广州市促进人工智能产业高质量发展实施方案》。重点推动智能网联汽车、智能无人系统、全屋智能终端、智能可穿戴设备、工业智能终端、脑机接口等智能硬件产品的研发推广，推动车载端侧大模型应用，支持开发家电—中控—传感器协同的AIoT系统。推动具身智能机器人商业化，支持企业自主研发核心零部件，拓展智能机器人在工业制造、家庭服务、医疗健康等领域的应用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-03-26/doc-inhsikav8959918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","BK4585","ROBO","BK4550","LABU","XBI","159760","IXJ","BK4588","BK4581","VHT"],"gpt_icon":0},{"id":"2622846858","title":"印孚瑟斯擬收購兩家美國諮詢公司，以加強醫療保健和保險技術產品組合","url":"https://stock-news.laohu8.com/highlight/detail?id=2622846858","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622846858?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 10:08","pubTimestamp":1774490887,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","LU0898667661.SGD","IE00BYTNYM70.SGD","LU0890818403.SGD","LU0531971678.HKD","LU0831103253.SGD","LU1267930656.SGD","LU1804176565.USD","BK4523","LU0791591158.USD","VHT","LU0791590937.USD","LU1508157978.USD","XBI","XLV","LU0868486357.SGD","INFY","IE00B7N09G41.SGD","LU0862451753.SGD","LU1366334578.USD","LU1323998911.USD","LU0287143357.SGD","BK4134","IE00B0JY6M65.USD","LU1366334651.USD","LU2087589342.USD","LU0164881194.USD","LU0348744763.USD","LU0708995666.HKD","LU0333810181.USD","LU0231203729.USD","BK4585","LU2663582299.SGD","LU0536402901.SGD","LU1805238398.USD","LU0066902890.USD","LU1102505762.USD","LU0431992006.USD","LU0197229882.USD","BK4581","LU2265009873.SGD","BK4535","IE00B3M56506.USD","BK4533","BK4550","LABU"],"gpt_icon":0},{"id":"1115632474","title":"醫療保健板塊動態速覽：市場焦點解析","url":"https://stock-news.laohu8.com/highlight/detail?id=1115632474","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115632474?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 00:22","pubTimestamp":1774455776,"startTime":"0","endTime":"0","summary":"0818 ET - William Blair分析师指出，默克以每股53美元收购Terns Pharmaceuticals的交易，未能充分体现这家生物技术公司前景广阔的白血病疗法的全部潜力。该机构在报告中强调，TERN-701有望颠覆慢性髓系白血病这一血癌的治疗模式，并对诺华Scemblix系列的主导地位构成挑战。分析师认为可能出现出价更优的竞购方，同时重申对Terns股票的\"跑赢大盘\"评级。Terns盘前上涨5.4%至52.71美元。双威医疗集团因近期上市取代QL资源入选指数。健身行业有望持续受益于消费者健康优先的行为转变。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSBC","BK4581","LABU","BK4588","XBI","BK4103","XLV","BK4220","M","BK4585"],"gpt_icon":0},{"id":"2622502641","title":"中銀基金青黃不接，新人李文廣成「帶頭大哥」","url":"https://stock-news.laohu8.com/highlight/detail?id=2622502641","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622502641?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 16:55","pubTimestamp":1774428900,"startTime":"0","endTime":"0","summary":"　　在新掌门人刘信群上任三个月后，银行系老牌公募中银基金“权益一哥”郑宁卸任了所有在管4只产品基金经理职务。　　据中银基金近日公告，因个人原因，郑宁卸任中银创新医疗、中银医疗保健、中银港股通医药、中银大健康的基金经理。　　在中银基金，郑宁成为基金经理，截至离任，基金经理从业年限也不满4年。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjyj/2026-03-25/doc-inhseyvu6769992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4581","VXUS","BK4585","XLV","XBI","BK4588"],"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":198,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XBI\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"高盛持倉","bkCode":"BK4581","id":"package_us_concept_gscc","changeRate":-0.009438},{"market":"US","name":"ETF&股票定投概念","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":-0.009432},{"market":"US","name":"碎股","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":-0.009428}]}}